Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Towards portable artificial kidneys: The role of advanced microfluidics and membrane technologies in implantable systems.

Dang BV, Taylor RA, Charlton AJ, Le-Clech P, Barber TJ.

IEEE Rev Biomed Eng. 2019 Aug 5. doi: 10.1109/RBME.2019.2933339. [Epub ahead of print]

PMID:
31395552
2.

Bictegravir and dolutegravir: head to head at 96 weeks.

Barber TJ.

Lancet HIV. 2019 Jun;6(6):e342-e343. doi: 10.1016/S2352-3018(19)30135-3. Epub 2019 May 5. No abstract available.

PMID:
31068271
3.

Flow-Mediated Drug Transport from Drug-Eluting Stents is Negligible: Numerical and In-vitro Investigations.

Vijayaratnam PRS, Reizes JA, Barber TJ.

Ann Biomed Eng. 2019 Mar;47(3):878-890. doi: 10.1007/s10439-018-02176-y. Epub 2018 Dec 14.

PMID:
30552528
4.

Dual-Mode Light Transduction through a Plastically Bendable Organic Crystal as an Optical Waveguide.

Catalano L, Karothu DP, Schramm S, Ahmed E, Rezgui R, Barber TJ, Famulari A, Naumov P.

Angew Chem Int Ed Engl. 2018 Dec 21;57(52):17254-17258. doi: 10.1002/anie.201810514. Epub 2018 Nov 27.

PMID:
30358048
5.

Having children outside a heterosexual relationship: options for persons living with HIV.

Barber TJ, Borok T, Suchak T, Weatherall A, Docherty T, Gamble N, Pralat R, Jaspal R, Cocker C.

Sex Transm Infect. 2019 Mar;95(2):99-101. doi: 10.1136/sextrans-2018-053670. Epub 2018 Oct 18. No abstract available.

PMID:
30337415
6.

Person-centred care and HIV: challenges and solutions.

Barber TJ, Saunders JM, Barnett N.

Sex Transm Infect. 2018 Dec;94(8):582-584. doi: 10.1136/sextrans-2018-053569. Epub 2018 Jul 4.

PMID:
29973388
7.

Correction to: CSF inflammatory markers and neurocognitive function after addition of maraviroc to monotherapy darunavir/ritonavir in stable HIV patients: the CINAMMON study.

Barber TJ, Imaz A, Boffito M, Niubó J, Pozniak A, Fortuny R, Alonso J, Davies N, Mandalia S, Podzamczer D, Gazzard B.

J Neurovirol. 2018 Jun;24(3):388-389. doi: 10.1007/s13365-017-0613-1.

PMID:
29318452
8.

CSF inflammatory markers and neurocognitive function after addition of maraviroc to monotherapy darunavir/ritonavir in stable HIV patients: the CINAMMON study.

Barber TJ, Imaz A, Boffito M, Niubó J, Pozniak A, Fortuny R, Alonso J, Davies N, Mandalia S, Podzamczer D, Gazzard B.

J Neurovirol. 2018 Feb;24(1):98-105. doi: 10.1007/s13365-017-0600-6. Epub 2017 Dec 26. Erratum in: J Neurovirol. 2018 Jan 9;:.

PMID:
29280108
9.

BASHH HIV and Blood Borne Virus Specialist Interest Group.

Barber TJ.

Sex Transm Infect. 2018 May;94(3):160. doi: 10.1136/sextrans-2017-053492. Epub 2017 Dec 22. No abstract available.

PMID:
29273590
10.

Integrating SANS and fluid-invasion methods to characterize pore structure of typical American shale oil reservoirs.

Zhao J, Jin Z, Hu Q, Jin Z, Barber TJ, Zhang Y, Bleuel M.

Sci Rep. 2017 Nov 13;7(1):15413. doi: 10.1038/s41598-017-15362-0.

11.

Highlights from the 9th IAS Conference on HIV Science, 23-26 July 2017, Paris, France.

Psomas CK, Barber TJ, Rutsaert S, Kinloch-de Loës S.

J Virus Erad. 2017 Oct 1;3(4):242-249. No abstract available.

12.

The Localized Hemodynamics of Drug-Eluting Stents Are Not Improved by the Presence of Magnetic Struts.

Vijayaratnam PR, Barber TJ, Reizes JA.

J Biomech Eng. 2017 Jan 1;139(1). doi: 10.1115/1.4035263.

PMID:
27893059
13.

Low levels of neurocognitive impairment detected in screening HIV-infected men who have sex with men: The MSM Neurocog Study.

Barber TJ, Bansi L, Pozniak A, Asboe D, Nelson M, Moyle G, Davies N, Margetts A, Ratcliffe D, Catalan J, Boffito M, Gazzard B.

Int J STD AIDS. 2017 Jun;28(7):715-722. doi: 10.1177/0956462416665061. Epub 2016 Aug 10.

PMID:
27510645
14.

Risks and benefits HIV preexposure prophylaxis with tenofovir/emtricitabine in an older male with comorbidities.

Girometti N, Jones R, Levy J, McCormack S, Sullivan A, Barber TJ.

AIDS. 2016 Aug 24;30(13):2131-3. doi: 10.1097/QAD.0000000000001171.

PMID:
27219131
15.

A cross-sectional study to evaluate the association of hyperbilirubinaemia on markers of cardiovascular disease, neurocognitive function, bone mineral density and renal markers in HIV-1 infected subjects on protease inhibitors.

Barber TJ, Moyle G, Hill A, Jagjit Singh G, Scourfield A, Yapa HM, Waters L, Asboe D, Boffito M, Nelson M.

HIV Clin Trials. 2016 May;17(3):123-30. doi: 10.1080/15284336.2016.1176305.

PMID:
27125367
16.

FLAMINGO: still in the pink?

Barber TJ, Pozniak A.

Lancet HIV. 2015 Apr;2(4):e116-7. doi: 10.1016/S2352-3018(15)00037-5. Epub 2015 Mar 10. No abstract available.

PMID:
26424668
17.

The Impact of Blood Rheology on Drug Transport in Stented Arteries: Steady Simulations.

Vijayaratnam PR, O'Brien CC, Reizes JA, Barber TJ, Edelman ER.

PLoS One. 2015 Jun 12;10(6):e0128178. doi: 10.1371/journal.pone.0128178. eCollection 2015.

18.

Effect of hyperbilirubinaemia on neurocognitive, renal, bone and cardiovascular markers in HIV infection treated with boosted protease inhibitors.

Barber TJ, Moyle G, Hill A, Singh GJ, Boffito M, Nelson M.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19827. doi: 10.7448/IAS.17.4.19827. eCollection 2014.

19.

Assessing the role of peripheral CD8 T cells in neurocognitive impairment in HIV-infected men who have sex with men: data from the MSM Neurocog Study.

Rawson TM, Dubb S, Pozniak A, Kelleher WP, Mandalia S, Gazzard B, Barber TJ.

Int J STD AIDS. 2015 Feb;26(2):128-32. doi: 10.1177/0956462414531934. Epub 2014 Apr 22.

PMID:
24759562
20.

HIV-related neurocognitive impairment screening: the patient's perspective on its utility and psychological impact.

Nightingale A, Ratcliffe D, Leonidou L, Margetts A, Asboe D, Gazzard B, Catalan J, Barber TJ.

AIDS Care. 2014;26(8):1036-41. doi: 10.1080/09540121.2014.894619. Epub 2014 Mar 13.

PMID:
24625218
21.

Manufacturing and wetting low-cost microfluidic cell separation devices.

Pawell RS, Inglis DW, Barber TJ, Taylor RA.

Biomicrofluidics. 2013 Sep 11;7(5):56501. doi: 10.1063/1.4821315. eCollection 2013. Erratum in: Biomicrofluidics. 2013 Oct 24;7(5):59901.

22.

Erratum: "Manufacturing and wetting low-cost microfluidic cell separation devices" [Biomicrofluidics 7, 056501 (2013)].

Pawell RS, Inglis DW, Barber TJ, Taylor RA.

Biomicrofluidics. 2013 Oct 24;7(5):59901. eCollection 2013.

23.

Screening for HIV-related neurocognitive impairment in clinical practice: challenges and opportunities.

Barber TJ, Bradshaw D, Hughes D, Leonidou L, Margetts A, Ratcliffe D, Thornton S, Pozniak A, Asboe D, Mandalia S, Boffito M, Davies N, Gazzard B, Catalan J.

AIDS Care. 2014 Feb;26(2):160-8. doi: 10.1080/09540121.2013.819401. Epub 2013 Jul 22. Review.

PMID:
23869661
24.

Two-dimensional computational analysis of microbubbles in hemodialysis.

Keshavarzi G, Barber TJ, Yeoh G, Simmons A, Reizes JA.

Artif Organs. 2013 Aug;37(8):E139-44. doi: 10.1111/aor.12110. Epub 2013 Jul 4.

PMID:
23826686
25.

Impact of flow pulsatility on arterial drug distribution in stent-based therapy.

O'Brien CC, Kolachalama VB, Barber TJ, Simmons A, Edelman ER.

J Control Release. 2013 Jun 10;168(2):115-24. doi: 10.1016/j.jconrel.2013.03.014. Epub 2013 Mar 27.

26.

Dolutegravir for treatment of HIV: SPRING forwards?

Waters LJ, Barber TJ.

Lancet. 2013 Mar 2;381(9868):705-6. doi: 10.1016/S0140-6736(12)62004-2. Epub 2013 Jan 8. No abstract available.

PMID:
23306001
27.

Analysis of drug distribution from a simulated drug-eluting stent strut using an in vitro framework.

O'Brien CC, Finch CH, Barber TJ, Martens P, Simmons A.

Ann Biomed Eng. 2012 Dec;40(12):2687-96. doi: 10.1007/s10439-012-0604-6. Epub 2012 May 31. Erratum in: Ann Biomed Eng. 2012 Dec;40(12):2697.

PMID:
22648579
28.

Frequency and patterns of protease gene resistance mutations in HIV-infected patients treated with lopinavir/ritonavir as their first protease inhibitor.

Barber TJ, Harrison L, Asboe D, Williams I, Kirk S, Gilson R, Bansi L, Pillay D, Dunn D; UK HIV Drug Resistance Database and UK Collaborative HIV Cohort (UK CHIC) Study Steering Committees.

J Antimicrob Chemother. 2012 Apr;67(4):995-1000. doi: 10.1093/jac/dkr569. Epub 2012 Jan 17.

PMID:
22258921
29.

Development of an in vitro method for modeling drug release and subsequent tissue drug uptake and deposition in a pulsatile flow network.

O'Brien CC, Finch CH, Martens P, Barber TJ, Simmons A.

Conf Proc IEEE Eng Med Biol Soc. 2011;2011:3262-5. doi: 10.1109/IEMBS.2011.6090886.

PMID:
22255035
30.

Outcomes in the first year after initiation of first-line HAART among heterosexual men and women in the UK CHIC Study.

Barber TJ, Geretti AM, Anderson J, Schwenk A, Phillips AN, Bansi L, Gilson R, Hill T, Walsh J, Fisher M, Johnson M, Post F, Easterbrook P, Gazzard B, Palfreeman A, Orkin C, Leen C, Gompels M, Dunn D, Delpech V, Pillay D, Sabin CA; UK CHIC Study Steering Committee.

Antivir Ther. 2011;16(6):805-14. doi: 10.3851/IMP1818.

PMID:
21900712
31.

Large eddy simulation of a stenosed artery using a femoral artery pulsatile flow profile.

Barber TJ, Simmons A.

Artif Organs. 2011 Jul;35(7):E155-60. doi: 10.1111/j.1525-1594.2011.01237.x. Epub 2011 Jun 9.

PMID:
21658078
32.

Postexposure prophylaxis for HIV following sexual exposure.

Barber TJ, Benn PD.

Curr Opin HIV AIDS. 2010 Jul;5(4):322-6. doi: 10.1097/COH.0b013e32833a5e6c. Review.

PMID:
20543608
33.

Audit of early syphilis: a North London comparison.

Barber TJ, Quartin M, Browne R.

Int J STD AIDS. 2010 Feb;21(2):151-2. doi: 10.1258/ijsa.2009.009430. No abstract available.

PMID:
20090007
34.

One-stop care for HIV-positive women.

Barber TJ, Coyne KM, Hawkins F, Desmond N.

Int J STD AIDS. 2009 Jan;20(1):67. doi: 10.1258/ijsa.2008.008366. No abstract available.

PMID:
19103902
35.

How does HIV impact on non-AIDS events in the era of HAART?

Barber TJ, Hughes A, Dinsmore WW, Phillips A.

Int J STD AIDS. 2009 Jan;20(1):1-3. doi: 10.1258/ijsa.2008.008302. Review.

PMID:
19103883
36.

How can we remove barriers to HIV testing outside of a GUM setting?

Barber TJ, Menon-Johansson A, Barton S.

Br J Gen Pract. 2008 May;58(550):365. doi: 10.3399/bjgp08X280308. No abstract available.

37.

Implanon failure and antiretroviral therapy.

Barber TJ, Waters L.

J Fam Plann Reprod Health Care. 2008 Jan;34(1):67; author reply 67. No abstract available.

38.

Are disulfiram-like reactions associated with abacavir-containing antiretroviral regimens in clinical practice?

Barber TJ, Marett B, Waldron S, Portsmouth S, Mackie NE, Weston R, Winston A.

AIDS. 2007 Aug 20;21(13):1823-4.

PMID:
17690585
40.

Structure and characterization of the murine p80 coilin gene, Coil.

Tucker KE, Massello LK, Gao L, Barber TJ, Hebert MD, Chan EK, Matera AG.

J Struct Biol. 2000 Apr;129(2-3):269-77.

PMID:
10806077

Supplemental Content

Loading ...
Support Center